| Product Code: ETC12561355 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Burkina Faso`s import of liver cancer drugs in 2024 saw significant contributions from top exporters such as India, France, Ghana, Morocco, and China. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for 2020-2024 was -0.46%. However, there was a notable growth rate of 10.24% from 2023 to 2024, indicating potential opportunities in the market. The continued presence of key exporting countries suggests a competitive landscape that could drive further developments in the liver cancer drugs import sector in Burkina Faso.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Liver Cancer Drugs Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Burkina Faso Liver Cancer Drugs Market - Industry Life Cycle |
3.4 Burkina Faso Liver Cancer Drugs Market - Porter's Five Forces |
3.5 Burkina Faso Liver Cancer Drugs Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Burkina Faso Liver Cancer Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Burkina Faso Liver Cancer Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Burkina Faso Liver Cancer Drugs Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Burkina Faso Liver Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of liver cancer in Burkina Faso |
4.2.2 Growing awareness about the importance of early detection and treatment of liver cancer |
4.2.3 Improvements in healthcare infrastructure and access to healthcare services in Burkina Faso |
4.3 Market Restraints |
4.3.1 High cost of liver cancer drugs and treatment |
4.3.2 Limited availability of advanced treatment options for liver cancer in Burkina Faso |
5 Burkina Faso Liver Cancer Drugs Market Trends |
6 Burkina Faso Liver Cancer Drugs Market, By Types |
6.1 Burkina Faso Liver Cancer Drugs Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.4 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.5 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.6 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2 Burkina Faso Liver Cancer Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Hepatocellular Carcinoma, 2021 - 2031F |
6.2.3 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Cholangiocarcinoma, 2021 - 2031F |
6.2.4 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Hepatoblastoma, 2021 - 2031F |
6.2.5 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Secondary Liver Cancer, 2021 - 2031F |
6.3 Burkina Faso Liver Cancer Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.5 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031F |
6.4 Burkina Faso Liver Cancer Drugs Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Sorafenib, 2021 - 2031F |
6.4.3 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Nivolumab, 2021 - 2031F |
6.4.4 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By Doxorubicin, 2021 - 2031F |
6.4.5 Burkina Faso Liver Cancer Drugs Market Revenues & Volume, By External Beam Radiation, 2021 - 2031F |
7 Burkina Faso Liver Cancer Drugs Market Import-Export Trade Statistics |
7.1 Burkina Faso Liver Cancer Drugs Market Export to Major Countries |
7.2 Burkina Faso Liver Cancer Drugs Market Imports from Major Countries |
8 Burkina Faso Liver Cancer Drugs Market Key Performance Indicators |
8.1 Number of liver cancer screenings conducted annually |
8.2 Percentage of liver cancer patients diagnosed at an early stage |
8.3 Adoption rate of new liver cancer drugs and treatment options in Burkina Faso |
9 Burkina Faso Liver Cancer Drugs Market - Opportunity Assessment |
9.1 Burkina Faso Liver Cancer Drugs Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Burkina Faso Liver Cancer Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Burkina Faso Liver Cancer Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Burkina Faso Liver Cancer Drugs Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Burkina Faso Liver Cancer Drugs Market - Competitive Landscape |
10.1 Burkina Faso Liver Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Burkina Faso Liver Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |